Koers Panacos Pharmaceuticals, Inc. Other OTC
Aandelen
PANC
US69811Q1067
Biotechnologie & Medisch Onderzoek
Omzet 2006 | 284K 265K | Omzet 2007 | 180K 168K | Marktkapitalisatie | 42,29 mln. 39,43 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2006 | -38 mln. -35,42 mln. | Nettowinst (verlies) 2007 | -37 mln. -34,49 mln. | EV/omzet 2006 | 504 x |
Nettoliquiditeiten 2006 | 60,4 mln. 56,31 mln. | Nettoliquiditeiten 2007 | 32,58 mln. 30,38 mln. | EV/omzet 2007 | 53,9 x |
K/w-verhouding 2006 |
-5,32
x | K/w-verhouding 2007 |
-1,12
x | Werknemers | - |
Dividendrendement 2006 * |
-
| Dividendrendement 2007 |
-
| Vrij verhandelbaar | 100% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
John R. Barr
CEO | Chief Executive Officer | 67 | - |
Thomas Higgins
DFI | Director of Finance/CFO | 72 | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+16,02% | 121 mld. | |
+19,95% | 113 mld. | |
+17,47% | 26,02 mld. | |
-25,01% | 19,39 mld. | |
-19,51% | 15,91 mld. | |
-18,38% | 15,09 mld. | |
-46,87% | 15,06 mld. | |
+63,16% | 14,93 mld. | |
+5,50% | 13,85 mld. |